A detailed history of Credit Suisse Ag transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 201,642 shares of HALO stock, worth $9.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
201,642
Previous 203,773 1.05%
Holding current value
$9.59 Million
Previous $7.53 Million 8.91%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$33.68 - $41.95 $71,772 - $89,395
-2,131 Reduced 1.05%
201,642 $8.2 Million
Q4 2023

Feb 08, 2024

SELL
$33.32 - $42.1 $119,085 - $150,465
-3,574 Reduced 1.72%
203,773 $7.53 Million
Q3 2023

Nov 13, 2023

SELL
$36.46 - $44.03 $702,657 - $848,546
-19,272 Reduced 8.5%
207,347 $7.92 Million
Q2 2023

Aug 11, 2023

BUY
$30.28 - $38.74 $1.47 Million - $1.88 Million
48,436 Added 27.18%
226,619 $8.17 Million
Q1 2023

May 10, 2023

BUY
$32.86 - $55.7 $132,688 - $224,916
4,038 Added 2.32%
178,183 $6.8 Million
Q4 2022

Feb 13, 2023

BUY
$40.06 - $59.44 $147,581 - $218,976
3,684 Added 2.16%
174,145 $9.91 Million
Q3 2022

Nov 10, 2022

BUY
$38.53 - $51.78 $180,397 - $242,433
4,682 Added 2.82%
170,461 $6.74 Million
Q2 2022

Aug 12, 2022

SELL
$37.35 - $48.3 $114,776 - $148,425
-3,073 Reduced 1.82%
165,779 $7.29 Million
Q1 2022

May 16, 2022

BUY
$31.97 - $41.06 $25,991 - $33,381
813 Added 0.48%
168,852 $6.73 Million
Q4 2021

Feb 14, 2022

SELL
$31.82 - $40.75 $225,890 - $289,284
-7,099 Reduced 4.05%
168,039 $6.76 Million
Q3 2021

Nov 12, 2021

BUY
$38.47 - $46.42 $941,822 - $1.14 Million
24,482 Added 16.25%
175,138 $7.13 Million
Q2 2021

Aug 16, 2021

SELL
$38.84 - $51.31 $189,383 - $250,187
-4,876 Reduced 3.14%
150,656 $6.84 Million
Q1 2021

May 14, 2021

SELL
$39.51 - $51.45 $4.12 Million - $5.37 Million
-104,386 Reduced 40.16%
155,532 $6.48 Million
Q4 2020

Feb 12, 2021

BUY
$25.81 - $43.62 $2.48 Million - $4.19 Million
96,066 Added 58.63%
259,918 $11.1 Million
Q3 2020

Nov 13, 2020

SELL
$25.74 - $29.63 $1.63 Million - $1.87 Million
-63,178 Reduced 27.83%
163,852 $4.31 Million
Q2 2020

Aug 12, 2020

BUY
$16.25 - $26.81 $2.1 Million - $3.47 Million
129,379 Added 132.49%
227,030 $6.09 Million
Q1 2020

May 13, 2020

SELL
$13.9 - $21.83 $1.12 Million - $1.75 Million
-80,336 Reduced 45.14%
97,651 $1.76 Million
Q4 2019

Feb 12, 2020

BUY
$14.93 - $19.53 $445,272 - $582,462
29,824 Added 20.13%
177,987 $3.16 Million
Q3 2019

Nov 12, 2019

SELL
$15.2 - $17.69 $1.19 Million - $1.39 Million
-78,335 Reduced 34.59%
148,163 $2.3 Million
Q2 2019

Aug 14, 2019

BUY
$14.75 - $17.26 $348,468 - $407,767
23,625 Added 11.65%
226,498 $3.89 Million
Q1 2019

May 14, 2019

BUY
$13.94 - $17.58 $644,139 - $812,336
46,208 Added 29.49%
202,873 $3.27 Million
Q4 2018

Feb 13, 2019

BUY
$13.33 - $18.66 $804,798 - $1.13 Million
60,375 Added 62.7%
156,665 $2.29 Million
Q3 2018

Nov 13, 2018

SELL
$16.68 - $18.41 $242,510 - $267,662
-14,539 Reduced 13.12%
96,290 $1.75 Million
Q2 2018

Aug 14, 2018

SELL
$16.87 - $20.3 $679,793 - $818,008
-40,296 Reduced 26.66%
110,829 $1.87 Million
Q1 2018

May 15, 2018

BUY
$17.06 - $21.2 $466,642 - $579,883
27,353 Added 22.1%
151,125 $2.96 Million
Q4 2017

Feb 14, 2018

SELL
$16.75 - $20.8 $2.54 Million - $3.16 Million
-151,686 Reduced 55.07%
123,772 $2.51 Million
Q3 2017

Nov 14, 2017

BUY
$11.76 - $17.4 $340,393 - $503,642
28,945 Added 11.74%
275,458 $4.78 Million
Q2 2017

Aug 14, 2017

BUY
N/A
246,513
246,513 $3.16 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.